{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:45:03Z","timestamp":1760708703768},"reference-count":123,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/j.cll.2014.02.010","type":"journal-article","created":{"date-parts":[[2014,4,12]],"date-time":"2014-04-12T02:21:44Z","timestamp":1397269304000},"page":"387-408","source":"Crossref","is-referenced-by-count":17,"title":["Antiviral Resistance in Influenza Viruses"],"prefix":"10.1016","volume":"34","author":[{"given":"Jennifer","family":"Laplante","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"St. George","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.cll.2014.02.010_bib1","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/jama.2009.294","article-title":"Infections with oseltamivir-resistant influenza A(H1N1) virus in the United States","volume":"301","author":"Dharan","year":"2009","journal-title":"JAMA"},{"issue":"46","key":"10.1016\/j.cll.2014.02.010_bib2","doi-asserted-by":"crossref","DOI":"10.2807\/ese.14.46.19412-en","article-title":"Oseltamivir-resistant influenza A(H1N1) viruses detected in Europe during season 2007-8 had epidemiologic and clinical characteristics similar to co-circulating susceptible A(H1N1) viruses","volume":"14","author":"Ciancio","year":"2009","journal-title":"Euro Surveill"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3201\/eid1502.081031","article-title":"Oseltamivir-resistant influenza viruses A (H1N1), Norway, 2007-08","volume":"15","author":"Hauge","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"10.1016\/j.cll.2014.02.010_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1056\/NEJMp068030","article-title":"Antiviral resistance in influenza viruses\u2013implications for management and pandemic response","volume":"354","author":"Hayden","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2014.02.010_bib5","first-page":"1487","article-title":"Orthomyxoviridae: the viruses and their replication","volume":"vol. 1","author":"Lamb","year":"2001"},{"issue":"13","key":"10.1016\/j.cll.2014.02.010_bib6","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase inhibitors for influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.cll.2014.02.010_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/cid\/cir001","article-title":"Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States","volume":"52","author":"Hernandez","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.cll.2014.02.010_bib8","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1128\/AAC.06456-11","article-title":"Intrapulmonary distribution and pharmacokinetics of laninamivir, a neuraminidase inhibitor, after a single inhaled administration of its prodrug, laninamivir octanoate, in healthy volunteers","volume":"56","author":"Ishizuka","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2014.02.010_bib9","first-page":"ii5","article-title":"Pharmacokinetics of oseltamivir: an oral antiviral for the treatment and prophylaxis of influenza in diverse populations","volume":"65","author":"Davies","year":"2010","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib10","doi-asserted-by":"crossref","first-page":"e1000786","DOI":"10.1371\/journal.ppat.1000786","article-title":"Efficacy of the new neuraminidase inhibitor CS-8958 against H5N1 influenza viruses","volume":"6","author":"Kiso","year":"2010","journal-title":"PLoS Pathog"},{"issue":"Suppl B","key":"10.1016\/j.cll.2014.02.010_bib11","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/jac\/18.Supplement_B.19","article-title":"Molecular basis of resistance of influenza A viruses to amantadine","volume":"18","author":"Hay","year":"1986","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib12","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1128\/JVI.62.5.1508-1512.1988","article-title":"Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection","volume":"62","author":"Belshe","year":"1988","journal-title":"J\u00a0Virol"},{"issue":"9492","key":"10.1016\/j.cll.2014.02.010_bib13","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0140-6736(05)67338-2","article-title":"Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern","volume":"366","author":"Bright","year":"2005","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib14","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1086\/518936","article-title":"Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide","volume":"196","author":"Deyde","year":"2007","journal-title":"J\u00a0Infect Dis"},{"issue":"44","key":"10.1016\/j.cll.2014.02.010_bib15","first-page":"1236","article-title":"Update: influenza activity\u2014United States, August 30-October 31, 2009","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"39","key":"10.1016\/j.cll.2014.02.010_bib16","first-page":"369","article-title":"Meetings of the WHO working group on surveillance of influenza antiviral susceptibility\u2014Geneva, November 2011 and June 2012","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"issue":"44\u201345","key":"10.1016\/j.cll.2014.02.010_bib17","first-page":"477","article-title":"Meeting of the WHO expert working group on surveillance of influenza antiviral susceptibility, Geneva, July 2013","volume":"88","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"issue":"8","key":"10.1016\/j.cll.2014.02.010_bib18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1086\/656439","article-title":"Recovery of a multidrug-resistant strain of pandemic influenza A 2009 (H1N1) virus carrying a dual H275Y\/I223R mutation from a child after prolonged treatment with oseltamivir","volume":"51","author":"Nguyen","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.cll.2014.02.010_bib19","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1056\/NEJMc1003749","article-title":"Emergence of a multidrug-resistant pandemic influenza A (H1N1) virus","volume":"363","author":"van der Vries","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.cll.2014.02.010_bib20","first-page":"1472","article-title":"Multidrug-resistant pandemic (H1N1) 2009 infection in immunocompetent child","volume":"17","author":"Eshaghi","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.cll.2014.02.010_bib21","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1128\/AAC.01699-10","article-title":"Combinatorial effect of two framework mutations (E119V and I222L) in the neuraminidase active site of H3N2 influenza virus on resistance to oseltamivir","volume":"55","author":"Richard","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"10.1016\/j.cll.2014.02.010_bib22","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.3201\/eid1711.110787","article-title":"Influenza B viruses with mutation in the neuraminidase active site, North Carolina, USA, 2010-11","volume":"17","author":"Sleeman","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"5983","key":"10.1016\/j.cll.2014.02.010_bib23","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1126\/science.1187816","article-title":"Permissive secondary mutations enable the evolution of influenza oseltamivir resistance","volume":"328","author":"Bloom","year":"2010","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib24","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/JCM.01732-10","article-title":"The I222V neuraminidase mutation has a\u00a0compensatory role in replication of an oseltamivir-resistant influenza virus A\/H3N2 E119V mutant","volume":"49","author":"Simon","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cll.2014.02.010_bib25","series-title":"Springer protocols\u2013influenza virus: methods and protocols","first-page":"53","article-title":"Diagnosis of influenza virus","author":"St. George","year":"2012"},{"issue":"1\u20132","key":"10.1016\/j.cll.2014.02.010_bib26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cccn.2005.04.038","article-title":"Pyrosequencing: history, biochemistry and future","volume":"363","author":"Ahmadian","year":"2006","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jviromet.2008.07.017","article-title":"A\u00a0new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1","volume":"153","author":"Duwe","year":"2008","journal-title":"J\u00a0Virol Methods"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.antiviral.2008.08.008","article-title":"Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza A viruses","volume":"81","author":"Deyde","year":"2009","journal-title":"Antiviral Res"},{"issue":"3","key":"10.1016\/j.cll.2014.02.010_bib29","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1128\/AAC.01417-09","article-title":"Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing","volume":"54","author":"Deyde","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.antiviral.2009.10.022","article-title":"Detection of antiviral resistance and genetic lineage markers in influenza B virus neuraminidase using pyrosequencing","volume":"85","author":"Sheu","year":"2010","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib31","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1586\/erm.09.21","article-title":"Influenza genome analysis using pyrosequencing method: current applications for a moving target","volume":"9","author":"Deyde","year":"2009","journal-title":"Expert Rev Mol Diagn"},{"issue":"1 Pt B","key":"10.1016\/j.cll.2014.02.010_bib32","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3851\/IMP2067","article-title":"Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods","volume":"17","author":"Nguyen","year":"2012","journal-title":"Antivir Ther"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib33","first-page":"44","article-title":"High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents\u2013United States, 2005-06 influenza season","volume":"55","author":"Centers for Disease Control and Prevention (CDC)","year":"2006","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"10.1016\/j.cll.2014.02.010_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1750-2659.2009.00103.x","article-title":"Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008","volume":"3","author":"Deyde","year":"2009","journal-title":"Influenza Other Respir Viruses"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib35","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1128\/JCM.01993-08","article-title":"Influenza antiviral resistance testing in New York and Wisconsin, 2006 to 2008: methodology and surveillance data","volume":"47","author":"Laplante","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib36","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/jmv.21692","article-title":"Development and implementation of influenza a virus subtyping and detection of genotypic resistance to neuraminidase inhibitors","volume":"82","author":"Ruiz-Carrascoso","year":"2010","journal-title":"J\u00a0Med Virol"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib37","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1093\/infdis\/jiq040","article-title":"Deep sequencing reveals mixed infection with 2009 pandemic influenza A (H1N1) virus strains and the emergence of oseltamivir resistance","volume":"203","author":"Ghedin","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.cll.2014.02.010_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jmoldx.2012.11.007","article-title":"Molecular assays for quantitative and qualitative detection of influenza virus and oseltamivir resistance mutations","volume":"15","author":"van der Vries","year":"2013","journal-title":"J\u00a0Mol Diagn"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib39","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jcv.2009.09.030","article-title":"Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase","volume":"47","author":"van der Vries","year":"2010","journal-title":"J\u00a0Clin Virol"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib40","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1128\/JCM.02540-09","article-title":"Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR","volume":"48","author":"Hindiyeh","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jcv.2010.06.019","article-title":"Diagnostic accuracy of an allele-specific reverse transcriptase-PCR assay targeting the H275Y oseltamivir resistant mutation in 2009 pandemic influenza A\/H1N1 virus","volume":"49","author":"Renaud","year":"2010","journal-title":"J\u00a0Clin Virol"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jviromet.2009.09.007","article-title":"Rapid quantification of single-nucleotide mutations in mixed influenza A viral populations using allele-specific mixture analysis","volume":"163","author":"Liu","year":"2010","journal-title":"J\u00a0Virol Methods"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib43","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jviromet.2010.10.005","article-title":"The validation of a real-time RT-PCR assay which detects influenza A and types simultaneously for influenza A H1N1 (2009) and oseltamivir-resistant (H275Y) influenza A H1N1(2009)","volume":"171","author":"Bennett","year":"2011","journal-title":"J\u00a0Virol Methods"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib44","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.jviromet.2011.02.014","article-title":"Development of a real-time RT-PCR assay for detection of resistance to oseltamivir in influenza A pandemic (H1N1) 2009 virus using single nucleotide polymorphism probes","volume":"173","author":"Wong","year":"2011","journal-title":"J\u00a0Virol Methods"},{"issue":"7","key":"10.1016\/j.cll.2014.02.010_bib45","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/jmv.22101","article-title":"Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A\/H1N1 2009 virus by duplex one-step RT-PCR assay","volume":"83","author":"Nakauchi","year":"2011","journal-title":"J\u00a0Med Virol"},{"issue":"10","key":"10.1016\/j.cll.2014.02.010_bib46","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1128\/JCM.01031-10","article-title":"Highly sensitive and quantitative detection of the H274Y oseltamivir resistance mutation in seasonal A\/H1N1 influenza virus","volume":"48","author":"Operario","year":"2010","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.cll.2014.02.010_bib47","doi-asserted-by":"crossref","first-page":"e21446","DOI":"10.1371\/journal.pone.0021446","article-title":"Rapid detection of the H275Y oseltamivir resistance mutation in influenza A\/H1N1 2009 by single base pair RT-PCR and high-resolution melting","volume":"6","author":"Tong","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.cll.2014.02.010_bib48","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1128\/JCM.00277-11","article-title":"Ultrasensitive detection of drug-resistant pandemic 2009 (H1N1) influenza A virus by rare-variant-sensitive high-resolution melting-curve analysis","volume":"49","author":"Chen","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"7","key":"10.1016\/j.cll.2014.02.010_bib49","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1007\/s10096-011-1482-9","article-title":"Rapid identification of neuraminidase inhibitor resistance mutations in seasonal influenza virus A(H1N1), A(H1N1)2009, and A(H3N2) subtypes by melting point analysis","volume":"31","author":"Redlberger-Fritz","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1\u20132","key":"10.1016\/j.cll.2014.02.010_bib50","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jviromet.2012.12.005","article-title":"Rapid detection of the S247N neuraminidase mutation in influenza A(H1N1)pdm09 virus by one-step duplex RT-PCR assay","volume":"188","author":"Takayama","year":"2013","journal-title":"J\u00a0Virol Methods"},{"issue":"10","key":"10.1016\/j.cll.2014.02.010_bib51","doi-asserted-by":"crossref","first-page":"4718","DOI":"10.1128\/AAC.00316-11","article-title":"Novel genotyping and quantitative analysis of neuraminidase inhibitor resistance-associated mutations in influenza a viruses by single-nucleotide polymorphism analysis","volume":"55","author":"Duan","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.cll.2014.02.010_bib52","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.antiviral.2009.09.010","article-title":"Detection of influenza A H1N1 and H3N2 mutations conferring resistance to oseltamivir using rolling circle amplification","volume":"84","author":"Steain","year":"2009","journal-title":"Antiviral Res"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib53","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1128\/JCM.01401-10","article-title":"Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method","volume":"49","author":"Suzuki","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib54","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.antiviral.2009.01.004","article-title":"Rapid identification of oseltamivir-resistant influenza A(H1N1) viruses with H274Y mutation by RT-PCR\/restriction fragment length polymorphism assay","volume":"82","author":"Guo","year":"2009","journal-title":"Antiviral Res"},{"issue":"10","key":"10.1016\/j.cll.2014.02.010_bib55","doi-asserted-by":"crossref","first-page":"e13293","DOI":"10.1371\/journal.pone.0013293","article-title":"Genomic signature-based identification of influenza A viruses using RT-PCR\/electro-spray ionization mass spectrometry (ESI-MS) technology","volume":"5","author":"Deyde","year":"2010","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.cll.2014.02.010_bib56","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1128\/JCM.01087-11","article-title":"High-resolution melting approach to efficient identification and quantification of H275Y mutant influenza H1N1\/2009 virus in mixed-virus-population samples","volume":"49","author":"Lee","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib57","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcv.2007.12.019","article-title":"Detection of adamantane-resistant influenza on a microarray","volume":"42","author":"Townsend","year":"2008","journal-title":"J\u00a0Clin Virol"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib58","doi-asserted-by":"crossref","first-page":"e8995","DOI":"10.1371\/journal.pone.0008995","article-title":"Single assay for simultaneous detection and differential identification of human and avian influenza virus types, subtypes, and emergent variants","volume":"5","author":"Metzgar","year":"2010","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.cll.2014.02.010_bib59","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1093\/nar\/gkq089","article-title":"Large-scale evolutionary surveillance of the 2009 H1N1 influenza A virus using resequencing arrays","volume":"38","author":"Lee","year":"2010","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib60","doi-asserted-by":"crossref","first-page":"e57154","DOI":"10.1371\/journal.pone.0057154","article-title":"Simultaneous detection of oseltamivir- and amantadine-resistant influenza by oligonucleotide microarray visualization","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.cll.2014.02.010_bib61","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1128\/JCM.00911-13","article-title":"Comparison of the FilmArray RP, Verigene RV+, and Prodesse ProFLU+\/FAST+ multiplex platforms for detection of influenza viruses in clinical samples from the 2011-2012 influenza season in Belgium","volume":"51","author":"Van Wesenbeeck","year":"2013","journal-title":"J\u00a0Clin Microbiol"},{"issue":"8","key":"10.1016\/j.cll.2014.02.010_bib62","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1128\/JCM.00642-11","article-title":"A\u00a0synonymous change in the influenza A virus neuraminidase gene interferes with PCR-based subtyping and oseltamivir resistance mutation detection","volume":"49","author":"Trevino","year":"2011","journal-title":"J\u00a0Clin Microbiol"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib63","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1128\/AAC.17.5.865","article-title":"Plaque inhibition assay for drug susceptibility testing of influenza viruses","volume":"17","author":"Hayden","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib64","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1006\/viro.1995.0058","article-title":"Generation and characterization of an\u00a0influenza virus neuraminidase variant with decreased sensitivity to the neuraminidase-specific inhibitor 4-guanidino-Neu5Ac2en","volume":"214","author":"Blick","year":"1995","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/(SICI)1099-1654(200001\/02)10:1<45::AID-RMV265>3.0.CO;2-R","article-title":"Monitoring of viral susceptibility: new challenges with the development of influenza NA inhibitors","volume":"10","author":"Tisdale","year":"2000","journal-title":"Rev Med Virol"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib66","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.antiviral.2009.11.005","article-title":"Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses","volume":"85","author":"Okomo-Adhiambo","year":"2010","journal-title":"Antiviral Res"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib67","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1086\/650465","article-title":"Current challenges in the risk assessment of neuraminidase inhibitor-resistant influenza viruses","volume":"201","author":"Gubareva","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"8","key":"10.1016\/j.cll.2014.02.010_bib68","doi-asserted-by":"crossref","first-page":"e23627","DOI":"10.1371\/journal.pone.0023627","article-title":"Real time enzyme inhibition assays provide insights into differences in binding of neuraminidase inhibitors to wild type and mutant influenza viruses","volume":"6","author":"Barrett","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2014.02.010_bib69","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/irv.12051","article-title":"Assays for monitoring susceptibility of influenza viruses to neuraminidase inhibitors","volume":"7","author":"Okomo-Adhiambo","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.cll.2014.02.010_bib70","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/978-1-61779-621-0_7","article-title":"The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors","volume":"865","author":"Hurt","year":"2012","journal-title":"Methods Mol Biol"},{"issue":"Suppl 2","key":"10.1016\/j.cll.2014.02.010_bib71","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/00333549131280S212","article-title":"Evaluation of three influenza neuraminidase inhibition assays for use in a public health laboratory setting during the 2011-2012 influenza season","volume":"128","author":"Murtaugh","year":"2013","journal-title":"Public Health Rep"},{"issue":"11","key":"10.1016\/j.cll.2014.02.010_bib72","doi-asserted-by":"crossref","first-page":"5209","DOI":"10.1128\/AAC.01086-13","article-title":"Bioluminescence-based neuraminidase inhibition assay for monitoring influenza virus drug susceptibility in clinical specimens","volume":"57","author":"Marjuki","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib73","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.antiviral.2011.04.010","article-title":"Mixed influenza A and B infections complicate the detection of influenza viruses with altered sensitivities to neuraminidase inhibitors","volume":"91","author":"Mohr","year":"2011","journal-title":"Antiviral Res"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib74","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3201\/eid1702.101724","article-title":"Characteristics of patients with oseltamivir-resistant pandemic (H1N1) 2009, United States","volume":"17","author":"Graitcer","year":"2011","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.cll.2014.02.010_bib75","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1086\/651605","article-title":"Rapid selection of oseltamivir- and peramivir-resistant pandemic H1N1 virus during therapy in 2 immunocompromised hosts","volume":"50","author":"Memoli","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.cll.2014.02.010_bib76","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.3201\/eid1610.100688","article-title":"Emergence of oseltamivir-resistant pandemic (H1N1) 2009 virus within 48 hours","volume":"16","author":"Inoue","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"9","key":"10.1016\/j.cll.2014.02.010_bib77","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1086\/651610","article-title":"Rapid selection of a transmissible multidrug-resistant influenza A\/H3N2 virus in an immunocompromised host","volume":"201","author":"Memoli","year":"2010","journal-title":"J\u00a0Infect Dis"},{"issue":"6","key":"10.1016\/j.cll.2014.02.010_bib78","doi-asserted-by":"crossref","first-page":"923","DOI":"10.3851\/IMP1635","article-title":"Emergence of intratreatment resistance to oseltamivir in pandemic influenza A H1N1 2009 virus","volume":"15","author":"Valinotto","year":"2010","journal-title":"Antivir Ther"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib79","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jcv.2013.06.003","article-title":"Different drug-resistant influenza A(H3N2) variants in two immunocompromised patients treated with oseltamivir during the 2011-2012 influenza season in Italy","volume":"58","author":"Piralla","year":"2013","journal-title":"J\u00a0Clin Virol"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib80","doi-asserted-by":"crossref","first-page":"e1003343","DOI":"10.1371\/journal.ppat.1003343","article-title":"Prolonged influenza virus shedding and emergence of antiviral resistance in immunocompromised patients and ferrets","volume":"9","author":"van der Vries","year":"2013","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.cll.2014.02.010_bib81","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM200302273480923","article-title":"Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient","volume":"348","author":"Weinstock","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.cll.2014.02.010_bib82","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/irv.12108","article-title":"Progressive emergence of an oseltamivir-resistant A(H3N2) virus over two courses of oseltamivir treatment in an immunocompromised paediatric patient","volume":"7","author":"Hurt","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"issue":"7","key":"10.1016\/j.cll.2014.02.010_bib83","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.3201\/eid1607.091248","article-title":"Long-term shedding of influenza A virus in stool of immunocompromised child","volume":"16","author":"Pinsky","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib84","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.antiviral.2012.09.001","article-title":"Design and synthesis of pinanamine derivatives as anti-influenza A M2 ion channel inhibitors","volume":"96","author":"Zhao","year":"2012","journal-title":"Antiviral Res"},{"issue":"8","key":"10.1016\/j.cll.2014.02.010_bib85","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1002\/jps.23644","article-title":"Conjugation to polymeric chains of influenza drugs targeting M2 ion channels partially restores inhibition of drug-resistant mutants","volume":"102","author":"Larson","year":"2013","journal-title":"J\u00a0Pharm Sci"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib86","first-page":"1","article-title":"Antiviral agents for the treatment and chemoprophylaxis of influenza \u2013 recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"60","author":"Fiore","year":"2011","journal-title":"MMWR Recomm Rep"},{"issue":"4","key":"10.1016\/j.cll.2014.02.010_bib87","doi-asserted-by":"crossref","first-page":"597","DOI":"10.3851\/IMP1804","article-title":"Neuraminidase of 2007-2008 influenza A(H1N1) viruses shows increased affinity for sialic acids due to the D344N substitution","volume":"16","author":"Rameix-Welti","year":"2011","journal-title":"Antivir Ther"},{"issue":"6","key":"10.1016\/j.cll.2014.02.010_bib88","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1093\/infdis\/jiq124","article-title":"Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients\u2013North Carolina, 2009","volume":"203","author":"Chen","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib89","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/infdis\/jis337","article-title":"Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia","volume":"206","author":"Hurt","year":"2012","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cll.2014.02.010_bib90","unstructured":"Centers for Disease Control and Prevention. 2013-2014 Influenza Season Week 2 ending January 11, 2014. Available at: http:\/\/www.cdc.gov\/flu\/weekly\/. Accessed January 17, 2014."},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib91","doi-asserted-by":"crossref","first-page":"e9332","DOI":"10.1371\/journal.pone.0009332","article-title":"Triple combination of amantadine, ribavirin, and oseltamivir is highly active and synergistic against drug resistant influenza virus strains in\u00a0vitro","volume":"5","author":"Nguyen","year":"2010","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.cll.2014.02.010_bib92","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/infdis\/jis265","article-title":"Combination antiviral therapy for influenza: predictions from modeling of human infections","volume":"205","author":"Perelson","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"12","key":"10.1016\/j.cll.2014.02.010_bib93","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1128\/AAC.05529-11","article-title":"Triple-combination antiviral drug for pandemic H1N1 influenza virus infection in critically ill patients on mechanical ventilation","volume":"55","author":"Kim","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.cll.2014.02.010_bib94","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP2475","article-title":"Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics","volume":"18","author":"Seo","year":"2013","journal-title":"Antivir Ther"},{"issue":"11","key":"10.1016\/j.cll.2014.02.010_bib95","doi-asserted-by":"crossref","first-page":"e1000362","DOI":"10.1371\/journal.pmed.1000362","article-title":"Efficacy of oseltamivir-zanamivir combination compared to each monotherapy for seasonal influenza: a randomized placebo-controlled trial","volume":"7","author":"Duval","year":"2010","journal-title":"PLoS Med"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib96","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/infdis\/jiq010","article-title":"Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors","volume":"203","author":"Pizzorno","year":"2011","journal-title":"J\u00a0Infect Dis"},{"issue":"23","key":"10.1016\/j.cll.2014.02.010_bib97","doi-asserted-by":"crossref","DOI":"10.2807\/ese.16.23.19884-en","article-title":"Increased detection in Australia and Singapore of a novel influenza A(H1N1)2009 variant with reduced oseltamivir and zanamivir sensitivity due to a S247N neuraminidase mutation","volume":"16","author":"Hurt","year":"2011","journal-title":"Euro Surveill"},{"issue":"9","key":"10.1016\/j.cll.2014.02.010_bib98","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1128\/AAC.00581-10","article-title":"Assessment of pandemic and seasonal influenza A (H1N1) virus susceptibility to neuraminidase inhibitors in three enzyme activity inhibition assays","volume":"54","author":"Nguyen","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"10.1016\/j.cll.2014.02.010_bib99","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S1473-3099(11)70318-8","article-title":"Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives","volume":"12","author":"Hurt","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.cll.2014.02.010_bib100","first-page":"25","article-title":"Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance","volume":"7","author":"McKimm-Breschkin","year":"2012","journal-title":"Influenza Other Respir Viruses"},{"issue":"4","key":"10.1016\/j.cll.2014.02.010_bib101","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1093\/jac\/dkl321","article-title":"Mutations conferring zanamivir resistance in human influenza virus N2 neuraminidases compromise virus fitness and are not stably maintained in\u00a0vitro","volume":"58","author":"Zurcher","year":"2006","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib102","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1128\/AAC.01608-09","article-title":"Detection of E119V and E119I mutations in influenza A (H3N2) viruses isolated from an immunocompromised patient: challenges in diagnosis of oseltamivir resistance","volume":"54","author":"Okomo-Adhiambo","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"10.1016\/j.cll.2014.02.010_bib103","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cid\/ciq183","article-title":"Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors","volume":"52","author":"Tamura","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.cll.2014.02.010_bib104","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/500465","article-title":"Recovery of drug-resistant influenza virus from immunocompromised patients: a case series","volume":"193","author":"Ison","year":"2006","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.cll.2014.02.010_bib105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3201\/eid1603.091321","article-title":"Rare influenza A (H3N2) variants with reduced sensitivity to antiviral drugs","volume":"16","author":"Dapat","year":"2010","journal-title":"Emerg Infect Dis"},{"issue":"17","key":"10.1016\/j.cll.2014.02.010_bib106","doi-asserted-by":"crossref","first-page":"8787","DOI":"10.1128\/JVI.00477-06","article-title":"Importance of neuraminidase active-site residues to the neuraminidase inhibitor resistance of influenza viruses","volume":"80","author":"Yen","year":"2006","journal-title":"J\u00a0Virol"},{"issue":"7","key":"10.1016\/j.cll.2014.02.010_bib107","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1128\/AAC.47.7.2264-2272.2003","article-title":"Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir","volume":"47","author":"McKimm-Breschkin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"10.1016\/j.cll.2014.02.010_bib108","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1128\/AAC.00555-08","article-title":"Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008","volume":"52","author":"Sheu","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib109","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1128\/JCM.41.2.742-750.2003","article-title":"Evaluation of neuraminidase enzyme assays using different substrates to measure susceptibility of influenza virus clinical isolates to neuraminidase inhibitors: report of the neuraminidase inhibitor susceptibility network","volume":"41","author":"Wetherall","year":"2003","journal-title":"J\u00a0Clin Microbiol"},{"issue":"3","key":"10.1016\/j.cll.2014.02.010_bib110","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1128\/JVI.72.3.2456-2462.1998","article-title":"Mutations in a conserved residue in the influenza virus neuraminidase active site decreases sensitivity to Neu5Ac2en-derived inhibitors","volume":"72","author":"McKimm-Breschkin","year":"1998","journal-title":"J\u00a0Virol"},{"issue":"11","key":"10.1016\/j.cll.2014.02.010_bib111","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1021\/jm010528u","article-title":"Structural studies of the resistance of influenza virus neuramindase to inhibitors","volume":"45","author":"Smith","year":"2002","journal-title":"J\u00a0Med Chem"},{"issue":"9436","key":"10.1016\/j.cll.2014.02.010_bib112","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(04)16934-1","article-title":"Resistant influenza A viruses in children treated with oseltamivir: descriptive study","volume":"364","author":"Kiso","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.cll.2014.02.010_bib113","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/508777","article-title":"Characterization of multidrug-resistant influenza A\/H3N2 viruses shed during 1 year by an immunocompromised child","volume":"43","author":"Baz","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.cll.2014.02.010_bib114","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/jac\/dkh528","article-title":"Characterization of recombinant influenza B viruses with key neuraminidase inhibitor resistance mutations","volume":"55","author":"Jackson","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib115","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1086\/314440","article-title":"Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus","volume":"178","author":"Gubareva","year":"1998","journal-title":"J\u00a0Infect Dis"},{"issue":"7","key":"10.1016\/j.cll.2014.02.010_bib116","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1128\/AAC.01339-05","article-title":"Detection of influenza viruses resistant to neuraminidase inhibitors in global surveillance during the first 3 years of their use","volume":"50","author":"Monto","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.cll.2014.02.010_bib117","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1128\/AAC.50.5.1872-1874.2006","article-title":"Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient","volume":"50","author":"Hurt","year":"2006","journal-title":"Antimicrob Agents Chemother"},{"issue":"13","key":"10.1016\/j.cll.2014.02.010_bib118","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1001\/jama.297.13.1435","article-title":"Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors","volume":"297","author":"Hatakeyama","year":"2007","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.cll.2014.02.010_bib119","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1128\/AAC.49.11.4515-4520.2005","article-title":"Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors","volume":"49","author":"Mishin","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"10.1016\/j.cll.2014.02.010_bib120","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jcv.2007.10.019","article-title":"Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors","volume":"41","author":"Escuret","year":"2008","journal-title":"J\u00a0Clin Virol"},{"issue":"4","key":"10.1016\/j.cll.2014.02.010_bib121","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/INF.0b013e3181ff863b","article-title":"Oseltamivir-resistant influenza A and B viruses pre- and postantiviral therapy in children and young adults with cancer","volume":"30","author":"Carr","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.cll.2014.02.010_bib122","doi-asserted-by":"crossref","first-page":"e1002249","DOI":"10.1371\/journal.ppat.1002249","article-title":"Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition","volume":"7","author":"Vavricka","year":"2011","journal-title":"PLoS Pathog"},{"issue":"24","key":"10.1016\/j.cll.2014.02.010_bib123","doi-asserted-by":"crossref","first-page":"13371","DOI":"10.1128\/JVI.01426-12","article-title":"Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors","volume":"86","author":"Zhu","year":"2012","journal-title":"J\u00a0Virol"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271214000249?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271214000249?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:30:26Z","timestamp":1648819826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271214000249"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":123,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S0272271214000249"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2014.02.010","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}